نتایج جستجو برای: herpes zoster neuralgia

تعداد نتایج: 47192  

Journal: :The Journal of infectious diseases 2011
Don Gilden Maria A Nagel Randall J Cohrs

Analysis of saliva samples from individuals aged ≥ 60 years who had a history of zoster (group 1), zoster and postherpetic neuralgia (PHN; group 2), or no history of zoster (group 3) revealed varicella zoster virus (VZV) DNA in saliva samples from 11 of 17 individuals in group 1, 10 of 15 individuals in group 2, and 2 of 17 individuals in group 3. The frequency of VZV DNA detection was signific...

Journal: :Expert review of pharmacoeconomics & outcomes research 2013
Xavier Bresse Lieven Annemans Emmanuelle Préaud Karine Bloch Gérard Duru Aline Gauthier

This study assesses the cost-effectiveness of vaccination against herpes zoster (HZ) and postherpetic neuralgia in France, using a published Markov model. The cost-effectiveness of vaccinating individuals aged from 65 years or between 70 and 79 years was evaluated over their lifetime, from a third-party payer perspective. French-specific data were combined with results from clinical studies and...

2013
Mélanie Drolet Michael N. Oxman Myron J. Levin Kenneth E. Schmader Robert W. Johnson David Patrick James A. Mansi Marc Brisson

Although progress has been made in the treatment of herpes zoster (HZ) and postherpetic neuralgia (PHN), available therapeutic options are only partially effective. Given evidence that a live-attenuated varicella-zoster-virus vaccine is effective at reducing the incidence of HZ, PHN and the burden of illness, policymakers and clinicians are being asked to make recommendations regarding the use ...

2013
Bernhard Ultsch Felix Weidemann Thomas Reinhold Anette Siedler Gérard Krause Ole Wichmann

BACKGROUND Herpes zoster (HZ) is a self-limiting painful skin rash affecting mostly individuals from 50 years of age. The main complication is postherpetic neuralgia (PHN), a long-lasting pain after rash has resolved. A HZ-vaccine has recently been licensed in Europe for individuals older than 50 years. To support an informed decision-making for a potential vaccination recommendation, we conduc...

2016
Wen-Yi Wang Sing-Huh Liu Meng-Yin Lin Che-Chen Lin I-Jong Wang

Herpes zoster (HZ) is associated with complications such as postherpetic neuralgia (PHN) and HZ ophthalmicus (HZO). However, few studies have focused on identifying patients having a high risk of PHN and HZO according to the initial presentation sites. The current study investigated these factors in a nationwide population-based cohort derived from Taiwan's Longitudinal Health Insurance Databas...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2014
S Coretti M Ruggeri P Codella

Background. Herpes zoster (HZ), or shingles, is a painful disease that results from reactivation of the varicella zoster virus (VZV) which has remained latent in sensory ganglia following primary infection i.e. varicella (VZV), a virus commonly acquired in childhood (chickenpox) [1]. The most common complication is post-herpetic neuralgia (PHN), a severe pain that can persist for months [2]. HZ...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015
Vicki A Morrison Gary R Johnson Kenneth E Schmader Myron J Levin Jane H Zhang David J Looney Robert Betts Larry Gelb John C Guatelli Ruth Harbecke Connie Pachucki Susan Keay Barbara Menzies Marie R Griffin Carol A Kauffman Adriana Marques John Toney Kathy Boardman Shu-Chih Su Xiaoming Li Ivan S F Chan Janie Parrino Paula Annunziato Michael N Oxman

BACKGROUND The Shingles Prevention Study (SPS) demonstrated zoster vaccine efficacy through 4 years postvaccination. A Short-Term Persistence Substudy (STPS) demonstrated persistence of vaccine efficacy for at least 5 years. A Long-Term Persistence Substudy (LTPS) was undertaken to further assess vaccine efficacy in SPS vaccine recipients followed for up to 11 years postvaccination. Study outco...

2011
Bernhard Ultsch Anette Siedler Thorsten Rieck Thomas Reinhold Gérard Krause Ole Wichmann

BACKGROUND Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus (VZV) and mainly affects individuals aged≥50 years. Vaccines have been licensed or are under development that can protect against HZ and its main complication postherpetic neuralgia (PHN). In Germany, the burden of disease caused by HZ is not well known. To support the decision making process related to a po...

2017
Cristiano Alicino Cecilia Trucchi Chiara Paganino Ilaria Barberis Sara Boccalini Domenico Martinelli Barbara Pellizzari Angela Bechini Andrea Orsi Paolo Bonanni Rosa Prato Stefania Iannazzo Giancarlo Icardi

Herpes Zoster (HZ) and its main complication, post-herpetic neuralgia (PHN), represent important public health issues because of their relevant burden among older adults. However, data on the epidemiology of HZ and PHN in Italy are very limited. A population-based study was performed by seeking for cases of HZ and PHN, occurred in the period 2013-2015, in the clinical charts of 56 General Pract...

Journal: :International Journal of Human Genetics 2022

This study aimed to explore the associations of OPRM1 A118G gene polymorphism with pain sensitivity and opioid dosage patients postherpetic neuralgia (PHN). According 3-month follow-up results, 103 PNH were enrolled as a PHN group, 112 without after herpes zoster included non-PHN group. The factors affecting occurrence subjected one-way analysis variance multivariate logistic regression analysi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید